US$ 29.79
bpc-157 ulcerative colitis phase ii clinical trial Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing | Cell and Tissue Research Frontiers | Stable Gastric Pentadecapeptide
Description
This product is supplied strictly for in-vitro laboratory research use only

Not for human consumption, medical, veterinary, or diagnostic use

Research into 5-Amino-1MQ is conducted under controlled laboratory conditions

At the December 2024 PCAC meeting, the committee evaluated CJC 1295 in multiple forms including the DAC variant
Preservation occurs through the inclusion of 0.9% benzyl alcohol, which inhibits bacterial reproduction by disrupting microbial cell membrane activity

ResearchGate preprint